Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Compound Cordyceps cicadae Tablets
- Development stage
- Preclinical
- Lead developer
- BioAsia Pharmaceutical
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
- Administration
- Oral
01
Overview
Compound Cordyceps cicadae Tablets (复方蝉花片) is a botanical and fungal-derived compound formulation developed by BioAsia Pharmaceutical (Zhejiang BioAsia Pharmaceutical). It is composed of Cordyceps cicadae (cicada flower) fruiting bodies and Pueraria lobata (kudzu root) extract. The formulation is developed as an adjuvant therapy to conventional hypoglycemic agents for patients with Type 2 diabetes mellitus. In a randomized clinical study of 109 patients, the adjuvant treatment with Compound Cordyceps cicadae Tablets demonstrated significant reductions in fasting blood glucose, 2-hour postprandial blood glucose, and glycosuria scores, while maintaining a favorable safety profile.
- Other names
- 复方蝉花片
02
Targets
AKT1 (Proto-oncogene serine/threonine-protein kinase Akt1)IL-6 (Interleukin 6)JNK (Mitogen-activated protein kinase kinase kinase family)TLR4 (Toll-like receptor 4)TP53 (Cellular Tumor Antigen p53 R175H)
Beyond the preview
Go deeper on Compound Cordyceps cicadae Tablets.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Compound Cordyceps cicadae Tablets.